Microfluidics-Based Biomarker Isolation and Detection
Isolate and detect rare biomarkers in blood samples, such as CTCs, cfDNA, and exosomes.
This technology allows large-volume, whole-blood processing with high biomarker recovery and purity. The technology is based on microfluidic isolation technology and has been clinically validated for six different cancer types. Source